Dr Reddys Laboratories (RDY) Intangibles (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Intangibles of $1.08 billion for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 4.7% from $1.14 billion a year earlier and down 0.8% from the prior quarter.
Dr Reddys Laboratories (RDY) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories posted Intangibles of $1.12 billion, down 1.2% from FY2025.
- Intangibles has a five-year compound annual growth rate of 18.1% (FY2021 to FY2026).
- By fiscal year, Intangibles came in at $1.13 billion in FY2025 (+156.0%), $443 million in FY2024 (+18.1%), $375 million in FY2023 (+4.5%) and $359 million in FY2022 (-26.3%).
- The fiscal Q2 2027 figure ranks as the lowest quarterly Intangibles since fiscal Q3 2025.
- Year over year, Intangibles has now declined in each of the last three quarters, with growth averaging 56.1% over the last eight quarters.
- The high point for year-over-year Intangibles in five years was fiscal Q4 2025 (growth of 155.4%); the low point was fiscal Q4 2022 (a decline of 26.0%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $1.09 billion (Q1 2027), $1.11 billion (Q4 2026) and $1.14 billion (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 1.08 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.08 Bn |
| Jun 30, 2026 | 1.09 Bn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.12 Bn |
| Mar 31, 2025 | 1.13 Bn |
| Dec 31, 2024 | 1.08 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 444.94 Mn |
| Mar 31, 2024 | 443.09 Mn |
| Dec 31, 2023 | 448.41 Mn |
| Sep 30, 2023 | 445.41 Mn |
| Jun 30, 2023 | 463.82 Mn |
| Mar 31, 2023 | 375.75 Mn |
| Dec 31, 2022 | 373.10 Mn |
| Sep 30, 2022 | 389.74 Mn |
| Jun 30, 2022 | 403.46 Mn |
| Mar 31, 2022 | 359.31 Mn |
| Dec 31, 2021 | 430.40 Mn |
Dr Reddys Laboratories Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=RDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();